Published in J Cell Biochem on December 15, 1996
Association of PI-3 kinase with PAK1 leads to actin phosphorylation and cytoskeletal reorganization. Mol Biol Cell (2002) 1.21
Expression of somatostatin and somatostatin receptor subtypes 1-5 in human normal and diseased kidney. J Histochem Cytochem (2008) 0.91
Effects of octreotide and insulin on colon cancer cellular proliferation and correlation with hTERT activity. Oncoscience (2014) 0.84
The role of morphine in animal models of human cancer: does morphine promote or inhibit the tumor growth? Biomed Res Int (2013) 0.81
Somatostatin and opioid receptors do not regulate proliferation or apoptosis of the human multiple myeloma U266 cells. J Exp Clin Cancer Res (2009) 0.81
Morphine Promotes Tumor Angiogenesis and Increases Breast Cancer Progression. Biomed Res Int (2015) 0.77
Receptorphin: a conserved peptide derived from the sequence of the opioid receptor, with opioid displacement activity and potent antiproliferative actions in tumor cells. BMC Pharmacol (2001) 0.76
Thyroid hormone and the kidney. Nephron (1975) 1.41
Regulation of actin organisation by TGF-beta in H-ras-transformed fibroblasts. J Cell Sci (1999) 1.28
Heterotypic and homotypic associations between the nuclear lamins: site-specificity and control by phosphorylation. Proc Natl Acad Sci U S A (1988) 1.26
Potent inhibitory action of red wine polyphenols on human breast cancer cells. J Cell Biochem (2000) 1.22
Differential regulation of the two RhoA-specific GEF isoforms Net1/Net1A by TGF-β and miR-24: role in epithelial-to-mesenchymal transition. Oncogene (2011) 1.20
Wine antioxidant polyphenols inhibit the proliferation of human prostate cancer cell lines. Nutr Cancer (2000) 1.15
Cell responses regulated by early reorganization of actin cytoskeleton. FEBS Lett (2008) 1.13
Heterogeneity of plasma glucagon: patterns in patients with chronic renal failure and diabetes. J Clin Endocrinol Metab (1976) 1.10
Hepatocyte swelling leads to rapid decrease of the G-/total actin ratio and increases actin mRNA levels. FEBS Lett (1992) 1.09
Pneumothorax complicating fatal bronchiolitis obliterans organizing pneumonia. Respiration (1999) 1.08
Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure. J Clin Invest (1976) 1.08
Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease. Am J Gastroenterol (2001) 1.08
Differences in the G/total actin ratio and microfilament stability between normal and malignant human keratinocytes. Cell Biochem Funct (1994) 1.07
TNF-alpha induces actin cytoskeleton reorganization in glomerular epithelial cells involving tyrosine phosphorylation of paxillin and focal adhesion kinase. Mol Med (1999) 1.04
Cytochalasin B may shorten actin filaments by a mechanism independent of barbed end capping. Biochem Pharmacol (1994) 1.01
Insulin binding and degradation by luminal and basolateral tubular membranes from rabbit kidney. J Clin Invest (1982) 1.00
Polyphenols and cancer cell growth. Rev Physiol Biochem Pharmacol (2007) 0.98
Insulin binding sites in various segments of the rabbit nephron. J Clin Invest (1983) 0.96
Interaction of opiates with opioid binding sites in the bovine adrenal medulla: II. Interaction with kappa sites. J Neurochem (1985) 0.95
Hepatic and renal metabolism of somatostatin-like immunoreactivity. Simultaneous assessment in the dog. J Clin Invest (1981) 0.94
Acute onset of dermatomyositis presenting in pregnancy with rhabdomyolysis and fetal loss. Scand J Rheumatol (1999) 0.94
Effect of hepatocyte swelling on microtubule stability and tubulin mRNA levels. Biochem Cell Biol (1994) 0.93
Morphine cross-reacts with somatostatin receptor SSTR2 in the T47D human breast cancer cell line and decreases cell growth. Cancer Res (1995) 0.92
Pathogenesis and characterization of hyperglucagonemia in the uremic rat. J Clin Invest (1976) 0.92
Nucleotide in monomeric actin regulates the reactivity of the thiol groups. Biochemistry (1984) 0.92
Antiproliferative and receptor binding properties of alpha- and beta-casomorphins in the T47D human breast cancer cell line. Eur J Pharmacol (1996) 0.90
Mechanism of impaired water excretion in the hypothyroid rat. J Clin Invest (1974) 0.89
Adrenal medullary opiate receptors. Pharmacological characterization in bovine adrenal medulla and a human pheochromocytoma. Mol Pharmacol (1984) 0.89
The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors. Eur J Pharmacol (1996) 0.89
Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors. Eur J Pharmacol (1997) 0.89
6-phospho-D-gluconate dehydrogenase from Pseudomonas fluorescens. Properties and subunit structure. Eur J Biochem (1983) 0.87
Human thyroid cancer: membrane thyrotropin binding and adenylate cyclase activity. J Clin Endocrinol Metab (1980) 0.87
Dexamethasone alters rapidly actin polymerization dynamics in human endometrial cells: evidence for nongenomic actions involving cAMP turnover. J Cell Biochem (1996) 0.87
Interaction of opiates with opioid binding sites in the bovine adrenal medulla: I. Interaction with delta and mu sites. J Neurochem (1985) 0.87
Tyrosine phosphorylation of focal adhesion kinase and paxillin regulates the signaling mechanism of the rapid nongenomic action of dexamethasone on actin cytoskeleton. Mol Med (1999) 0.87
The cytoskeleton in cell volume regulation. Contrib Nephrol (1998) 0.87
Identification of a novel opioid peptide (Tyr-Val-Pro-Phe-Pro) derived from human alpha S1 casein (alpha S1-casomorphin, and alpha S1-casomorphin amide). Biochem J (1996) 0.87
Heat shock protein HSP90 and its association with the cytoskeleton: a morphological study. Biochem Cell Biol (1992) 0.86
Dexamethasone induces rapid actin assembly in human endometrial cells without affecting its synthesis. J Cell Biochem (1997) 0.86
Expression and characterization of Cys374 mutated human beta-actin in two different mammalian cell lines: impaired microfilament organization and stability. FEBS Lett (1999) 0.84
Role of the kidney in metabolism of gonadotropins in rats. Am J Physiol (1984) 0.84
Na+/Pi co-transport alters rapidly cytoskeletal protein polymerization dynamics in opossum kidney cells. Biochem J (1996) 0.84
Actin cytoskeleton: a signaling sensor in cell volume regulation. Cell Physiol Biochem (2000) 0.84
Matrix metalloproteinases and their inhibitors in acute viral hepatitis. J Viral Hepat (2002) 0.84
The molecular mechanism of interaction of Et3Pb+ with tubulin. FEBS Lett (1984) 0.83
Regulation of the promoter of the human corticotropin-releasing hormone gene in transfected human endometrial cells. Neuroendocrinology (1996) 0.83
Early alterations of actin cytoskeleton in OK cells by opioids. J Cell Biochem (1998) 0.83
The transcription of corticotropin-releasing hormone in human endometrial cells is regulated by cytokines. Neuroendocrinology (1999) 0.83
Opioids suppress basal and nicotine-induced catecholamine secretion via a stabilizing effect on actin filaments. Endocrinology (2001) 0.83
Evidence for high peptide alpha-amidation activity in the neonatal rat pancreas. Biochem Biophys Res Commun (1986) 0.82
Are opioid peptides co-localized with vasopressin or oxytocin in the neural lobe of the rat? Cell Tissue Res (1986) 0.82
Corticotrophin-releasing hormone (CRH) interacts with inflammatory prostaglandins and interleukins and affects the decidualization of human endometrial stroma. Mol Hum Reprod (2000) 0.82
The corticotropin-releasing hormone (CRH) in normal and tumoral epithelial cells of human endometrium. J Clin Endocrinol Metab (1995) 0.82
PLC-gamma1 signaling pathway and villin activation are involved in actin cytoskeleton reorganization induced by Na+/Pi cotransport up-regulation. Mol Med (2000) 0.82
Normal and Ha-ras-1 oncogene transformed Buffalo rat liver (BRL) cells show differential resistance to cytoskeletal protein inhibitors. Cell Biochem Funct (1992) 0.81
Metabolism of polypeptide hormones by the normal kidney and in uremia. Nephron (1978) 0.80
Evidence for high peptide alpha-amidating activity in the pancrease from neonatal rats. Proc Natl Acad Sci U S A (1987) 0.80
Glucagon metabolism in the rat. J Clin Invest (1978) 0.80
Regional distribution of methionine-enkephalin-Arg6-Phe7 in the rat brain: comparative study with the distribution of other opioid peptides. J Neurochem (1983) 0.80
Opioid agonists modify breast cancer cell proliferation by blocking cells to the G2/M phase of the cycle: involvement of cytoskeletal elements. J Cell Biochem (1999) 0.79
Heterogeneity of plasma glucagon in man. Metabolism (1976) 0.79
Nephrotic syndrome caused by minimal-change disease in a patient with focal proliferative SLE nephritis (WHO III) in remission. Nephrol Dial Transplant (1998) 0.79
Opioids are non-competitive inhibitors of nitric oxide synthase in T47D human breast cancer cells. Cell Death Differ (2001) 0.79
Marked proteinuria in hypertensive nephrosclerosis. Am J Nephrol (1985) 0.79
Kappa1-opioid binding sites are the dominant opioid binding sites in surgical specimens of human pheochromocytomas and in a human pheochromocytoma (KAT45) cell line. Eur J Pharmacol (1999) 0.79
Urinary concentration and dilution after unilateral nephrectomy in the rat. Clin Sci Mol Med (1975) 0.78
Endometrial corticotropin-releasing hormone: expression, regulation, and potential physiological implications. Ann N Y Acad Sci (1997) 0.78
Metabolism of pure human erythropoietin in the rat. Am J Physiol (1984) 0.78
Adrenocorticotropin, and corticosterone secretion in Brattleboro rats. Endocrinology (1982) 0.78
The antiglucocorticoid RU486 downregulates the expression of interleukin-2 receptors in normal human lymphocytes. J Steroid Biochem Mol Biol (1991) 0.78
Effect of neonatal treatment with monosodium glutamate on the secretion of alpha-MSH, beta-endorphin and ACTH in the rat. Neuroendocrinology (1981) 0.78
Prolactin metabolism in the rat: role of the kidney in degradation of the hormone. Am J Physiol (1981) 0.78
Identification and characterization of opioid-binding sites present in the Ishikawa human endometrial adenocarcinoma cell line. J Clin Endocrinol Metab (1995) 0.78
The interaction of triethyl lead with tubulin and microtubules. Mutat Res (1988) 0.78
Plasma glucagon, insulin and glucose responses to intravenous arginine infusion in the rat. Horm Metab Res (1978) 0.78
Acidification reveals a greater number of epidermal growth factor receptors in human placental and breast cancer membranes. Clin Chim Acta (1994) 0.78
Water channel expression in human ADPKD kidneys. Am J Physiol (1995) 0.78
Reassessment of opioid binding sites in the rat brain. Neuropeptides (1986) 0.77
Pattern of prolactin diurnal secretion in normal humans: evidence for nonlinear dynamics. Neuroendocrinology (1995) 0.77
Modulation of the estrogen-regulated proteins cathepsin D and pS2 by opioid agonists in hormone-sensitive breast cancer cell lines (MCF7 and T47D): evidence for an interaction between the two systems. J Cell Biochem (1998) 0.77
Corticotropin-releasing hormone (CRH) is expressed at the implantation sites of early pregnant rat uterus. Life Sci (1995) 0.77
Low stimulation of peripheral lymphocytes, following in vitro application of Emdogain. J Clin Periodontol (1998) 0.77
Estrogens and glucocorticoids induce the expression of c-erbB2/NEU receptor in Ishikawa human endometrial cells. Life Sci (1997) 0.77
TRH and TRH-OH in the pancreas of adult and newborn rats. Life Sci (1985) 0.77
Pathogenesis of endocrine abnormalities in uremia. Endocr Rev (1980) 0.77